Skip to main content

Quipt Announces the Passing of Board Member Eugene Ewing

CINCINNATI, Jan. 12, 2022 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, is regrettably announcing the passing of Eugene Ewing, Independent Board Member and Chair of the Audit Committee. Mr. Ewing was an accomplished and seasoned public company executive with a wealth of knowledge across a variety of industry groups.

“Eugene’s wealth of experience, business acumen and strategic guidance will be greatly missed. Eugene was an integral part of assisting us in reaching our goal of building a world-class respiratory care company in the United States and his contributions over the years will not be forgotten. On behalf of the Board, and the entire Quipt team, I want to express my deepest condolences to Eugene’s family,” said Greg Crawford, Chairman and CEO of Quipt. “Our management team is exceptionally excited about the future and we will continue driving forward in the wake of this saddening news.”

Prior to Mr. Ewing passing, the Board of Directors began the process of identifying highly qualified candidates for addition to the Board, and currently has a short list of candidates. The Board is focussed on identifying a candidate to fulfill the role of Independent Director and Chair of the Audit Committee.

Mr. Ewing served on Quipt’s Board and Chaired the Audit Committee since September 2018. Mr. Ewing had over 30 years of professional experience in a wide range of executive positions serving as an independent director of a New York Stock Exchange listed company focused on creating sustainable food, feed and fuel solutions from organic by-products. He also served as an independent director at a separate New York Stock Exchange listed company that owns and manages controlling interests in a diverse family of established North American middle market businesses.

In addition to his public company roles, Mr. Ewing had been the managing member of Deeper Water Consulting, a private wealth and business consulting company, since March of 2004. Previously, Mr. Ewing held senior positions at the Fifth Third Bank, and was a tax partner at Arthur Andersen LLP for over 15 years, in Cincinnati, Ohio. Mr. Ewing was also on the Advisory Board for the Von Allmen School of Accountancy at the University of Kentucky and was a director of a private trust company located in Wyoming and a private consulting company located in California.

ABOUT QUIPT HOME MEDICAL CORP.

The Company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility and other chronic health conditions. The primary business objective of the Company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The Company’s organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient’s services, and making life easier for the patient.

Forward-Looking Statements

For further information please visit our website at www.Quipthomemedical.com, or contact:

Cole Stevens
VP of Corporate Development
859-300-6455
cole.stevens@myquipt.com

Gregory Crawford
Chief Executive Officer
Quipt Home Medical Corp.
859-300-6455
investorinfo@myquipt.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of ‎the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.‎

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.